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Background: Although many hospital readmission reduction initiatives
have been introduced globally, health care systems ultimately aim to
improve patients’ health and well-being. We examined whether the
hospitals that report greater success in reducing readmissions also see
greater improvements in patient-reported outcomes.
Research Design: We examined hospital groups (Trusts) that
provided hip replacement or knee replacement surgery in England
between April 2010 and February 2013. For each Trust, we calculated
risk-adjusted 30-day readmission rates from administrative datasets. We
also obtained changes in patient-reported health between presurgical
assessment and 6-month follow-up, using general health EuroQuol five
dimensions questionaire (EQ-5D) and EuroQuol visual analogue scales
(EQ-VAS) and procedure-specific (Oxford Hip and Knee Scores)
measures. Panel models were used to assess whether changes over time
in risk-adjusted readmission rates were associated with changes over
time in risk-adjusted health gains.
Results: Each percentage point reduction in the risk-adjusted re-
admission rate for hip replacement was associated with an addi-
tional health gain of 0.004 for EQ-5D [95% confidence interval
(CI), 0.002–0.006], 0.39 for EQ-VAS (95% CI, 0.26–0.52), and
0.32 for Oxford Hip Score (95% CI, 0.15–0.27). Corresponding
figures for knee replacement were 0.003 for EQ-5D (95% CI,
0.001–0.004), 0.21 for EQ-VAS (95% CI, 0.12–0.30), and 0.14 in
the Oxford Knee Score (95% CI, 0.09–0.20).
Conclusions: Reductions in readmission rates were associated with
modest improvements in patients’ sense of their health and well-
being at the hospital group level. In particular, fears that efforts to
reduce readmission rates have had unintended consequences for
patients appear to be unfounded.
Key Words: readmission rates, patient-reported outcome measures,
hip and knee replacement surgery, quality of care
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England and the United States have incorporated financialpenalties for hospitals with high readmission rates into their
payment systems.1 The English changes were introduced in
2011 as part of a substantial reform package to reduce avoidable
unplanned readmissions.2 In the first year, hospitals providing
care for National Health Service (NHS) patients received no
reimbursement for readmissions that occurred within 30 days of
discharge where the index admission was planned (such for
elective surgeries). For unplanned indexed admission (eg, via
emergency departments), reimbursement occurred up to a
threshold that was designed to reflect the readmission rate ex-
pected to occur even with high-quality care. From April 2012,
this threshold was applied to determine reimbursement for all
readmissions, regardless of the nature of the indexed admission,
with monies accumulated from penalties largely being re-
invested into postdischarge rehabilitation services. The US
program [Hospital Readmission Reduction Program (HRRP)]
was introduced in 2012, originally for acute myocardial in-
farction, heart failure and pneumonia, and in financial year 2015
was extended to cover hip and knee replacement and chronic
obstructive pulmonary disease. Following HRRP’s introduction,
readmission rates for the targeted conditions have fallen in the
United States, from 21.5% in 2007 to 17.8% in 2015,3,4 possibly
as a consequence of enhanced efforts stemming from HRRP.5
The focus on readmission rates has arisen partly because
of their link to the quality and safety of the initial hospital
stay,6,7 transitional care services,8–10 and postdischarge sup-
port.11,12 However, while those associations have helped to es-
tablish the evidence base for using readmissions as a quality
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measure, it has been unclear how they relate to other domains of
health care quality and in particular, patients’ own sense of
health and well-being.13 Answering this question has proven
difficult due to the lack of a systematic approach to collecting
patient-reported outcome measures (PROMs) in many health
care systems but, in this paper, we use a novel dataset from the
English NHS, which contains PROMs for over 270,000 patients
undergoing hip or knee replacement surgery since 2009.14 We
focus on hip and knee replacements, as these are both common
elective surgeries meant to improve patients’ functional out-
comes though have substantial 30-day readmission rates (8.5%
and 5.5%, respectively),15,16 relevant to the HRRP expansion
and the readmission penalties in England.
Various initiatives have been introduced to reduce re-
admissions following hip and knee replacement in England.
These include “enhanced recovery programs” consisting of
preoperative education, new anesthetic techniques, and post-
operative rehabilitation plans17; nurse-led telephone helplines
that offer advice following hospital discharge18; and orthope-
dic outreach services offering follow-up care outside of hos-
pital settings.19 Each intervention may have affected both
readmission rates (eg, by strengthening the patients’ ability to
self-care, including managing pain or dressing wounds) and
patient-reported health outcomes such as mobility or pain
(eg, through exercise management). However, even though
specific interventions have been evaluated individually,20 it is
still unclear whether, at a system level, reductions in read-
mission rates have coincided with improvements in broader
patient outcomes. Assessing the association between these 2 is
critical because of concerns that, by incentivizing hospitals
to reduce readmission rates, there may have been unintended
consequences for other aspects of care quality,21–24 for example,
if the penalties displaced follow-up activity from inpatient set-
tings to other care settings (such as observation units) that are not
included in the readmission metrics yet might have implications
for patient care4; or had disproportionate impacts on some
hospitals groups.25,26
Clearly, if a focus on readmission rates is having detri-
mental impacts on other patient outcomes, then the implications
will warrant careful attention, and some corrective action may be
needed for national policy or local implementation.27 If, how-
ever, changes in readmission rates and PROMs are independent,
then this might suggest that incentives to lower readmission rates
cannot be relied upon to improve these aspects of care, and that
(even though readmission penalties bring benefits) they might
need to be supplemented with other approaches to improve
patient-reported health gains. As no studies have been able to
examine associations between readmissions and patient-reported
outcomes at the institutional-level, we use the novel data from
the English NHS to examine whether those hospitals that showed
larger improvements in readmission rates also showed larger
improvements in patients’ long-term self-assessments of health
gain following surgery.
METHODS
Study Sample
We focused on the period beginning with the pub-
lication of the 2010 Government white paper that introduced
many readmission reduction initiatives in England,28 and
ending with a major reorganization of the NHS in 2013. We
studied all NHS Trusts (health care providers that can
combine a number of hospital sites, with on an average 3
orthopedic units each)29 that conducted hip and knee sur-
geries during this period, regardless of procedure volume.
We used the Hospital Episode Statistics (HES) database
to identify patients who underwent hip or knee replacement
surgery at NHS Trusts. HES is a national administrative da-
tabase, containing information on patient characteristics, di-
agnoses, and treatments for all admissions to NHS Trusts in
England. We included both primary and revision surgeries for
the hip and knee surgeries, defined using the Classification of
Intervention and Procedure Codes (OPCS-4) given in
Appendix A (Supplemental Digital Content 1, http://links.
lww.com/MLR/B446 and Supplemental Digital Content 2,
http://links.lww.com/MLR/B447).30
We studied all patients aged 18 or over undergoing a
planned hip and knee replacement between April 1, 2010 and
February 28, 2013. Patients undergoing hip or knee surgery
in March 2013 were excluded to allow for sufficient follow-
up to calculate 30-day readmission rates within the con-
straints of the available data. We also excluded patients for
whom we were lacking the requisite data for risk-adjustment
(see below). Patients experiencing multiple admissions for a
hip or knee replacement were treated as separate ob-
servations in the analysis, provided both admission episodes
were separated by >30 days.
Readmission Rates
We calculated readmissions rates using HES data in a
way that is consistent with national readmission reduction
policies in England, namely as all-cause, unplanned admis-
sions occurring within 30 days of discharge following an
index admission for hip or knee replacement. We risk-
adjusted the readmission rates by conducting logistic re-
gression at the patient level, adjusting for age, sex, ethnicity,
comorbidities based on the Charlson Index, socioeconomic
deprivation score (Index of Multiple Deprivation based on
small geographic areas, each containing on an average 1500
residents),31 and length of stay. Consistent with the risk-
adjustment methodology for PROMs (see below), we cal-
culated risk-adjusted readmission rates at the Trust level, for
each financial year, by taking the ratio of observed to pre-
dicted readmissions for the Trust, and multiplying this ratio
by the average readmission rate across all Trusts.
PROMs
Unlike many other health care systems, the NHS has
collected information on patient-reported outcome measures
since 2009. Intended to encourage transparent reporting of
variations in care and to promote increases in efficiency,32
the PROMs program covers the treatment of varicose veins,
hip and knee replacements, and hernia repair.33 Patients are
asked to complete 1 questionnaire at preoperative assessment
or on admission. Respondents to that first questionnaire are
then mailed a postoperative survey 6 months after their
procedure, including 1 reminder for nonresponders.
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We assessed changes in health gain following hip and
knee replacement surgery using both general EuroQuol five
dimensions questionaire (EQ-5D) and EuroQuol visual ana-
logue scales (EQ-VAS) and procedure-specific (Oxford Hip
Score and Oxford Knee Score) instruments. EQ-5D is a general
measure of quality-of-life, and consists of 5 dimensions, namely
patient mobility, self-care, activity status, pain/discomfort, and
anxiety/depression. Patient assessments were converted into
quality-of-life scores using utilities derived from trade-offs
within a representative population (UK), and range from 0.59
(worse than death), through 0.00 (dead) to 1.00 (perfect health).
EQ-VAS measures subjective health status using a single
graphical scale, which ranges between 0 and 100. The Oxford
Hip and Knee Scores were developed to measure health out-
comes following these specific procedures,34 such as functional
status, including limping when walking due to the hip or knee.
Both questionnaires include 12 items with 4 dimensions, and
produce scores that range between 0 (severe symptoms and
disability) and 48 (no problems). Previous research has as-
sumed that, to be clinically significant, a minimal difference is
required equal to 0.14 for EQ-5D, 8.4 for the Oxford Hip Score,
and 3.8 for the Oxford Knee Score.35 However, these differ-
ences are for individual patients and may not be appropriate for
judging the means of populations.
Risk-adjustment of PROMs
We used publicly available summaries of PROMs data,
reported for each Trust and financial year by the NHS Digi-
tal.36 These data relate to average, risk-adjusted changes in
health gain among the patients who returned both
preoperative and postoperative questionnaires. The risk-
adjustment was based on applying ordinary least squares re-
gression models to the postquestionnaire score, adjusting for
patient age, sex, comorbidities (self-reported), socioeconomic
deprivation score, patient self-reported health status (from the
preoperative questionnaire), discharge destination, length of
stay, and timing of questionnaire completion.37 For each
Trust and financial year, the observed mean postoperative
score was divided by the predicted mean postoperative score
to indicate the extent to which the provider over or under-
performed relative to the level expected. That ratio was then
multiplied by the national average postoperative score to
estimate the postoperative score that would have been ach-
ieved by the Trust had they treated a national average case-
mix of patients. Finally, the risk-adjusted health gain for a
given Trust was calculated by subtracting the national aver-
age preoperative PROMs score from the Trust-specific risk-
adjusted postoperative PROMs score.
We linked the readmissions and PROMs data, sepa-
rately for each operation (hip and knee replacement), Trust,
and financial year (2010/2011, 2011/2012, and 2012/2013).
We also assembled data on response rates for each Trust for
use in the statistical analysis.
Statistical Analysis
Our analysis was conducted at the Trust level, and
separately for each procedure (hip and knee replacement)
and for the 3 corresponding PROMs. We used panel data
models38 that make use of PROMs information across
multiple Trusts and time periods. In effect, these assessed
whether changes over time in risk-adjusted readmission rates
were related to changes over time in risk-adjusted health
gains in the same Trusts. This approach deals with
confounding due to differences in the characteristics of
Trusts (whether observed and unobserved) provided the re-
lationship between these characteristics and the outcome is
constant over time. We used generalized least squares
regression estimators with the risk-adjusted health gain as the
dependent variable, and the risk-adjusted readmission rate as
the explanatory variable.
We used the Hausman model specification test to
determine whether Trusts should be entered as fixed or
random effects in the panel data models, and as a result
preferred random effects for all knee replacement models.
For hip replacement, we preferred fixed effects when mod-
eling EQ-5D and EQ-VAS, and random effects for the Ox-
ford Hip Scores (see Appendix B, Supplemental Digital
Content 3, http://links.lww.com/MLR/B448). We report the
goodness of model fit using the R2 statistics.
We tested several approaches to handling nonresponse
to the PROMs data. First, we constructed regression models
without controlling for response rates. Second, we entered the
time-varying, Trust-level response rate into the regressions as
an additional adjustment variable. Third, we repeated our
modeling for Trusts reporting a minimum response rate of
60%. We also tested the impact of controlling for the Trust’s
mortality rate, which we calculated using data on deaths that
occurred in hospital within 6 months of discharge.
Approach to Missing Data and Sensitivity
Analysis
In some cases, data were missing for entire Trusts, either
because PROMs data were unreported or because the Trusts had
not been in existence for the entire period. In our main analysis,
we included Trusts without PROMs data for 1 year, and thus
required only that Trusts reported data for Z2 years (thus, we
had an unbalanced panel). As a sensitivity analysis, we con-
structed a strictly balanced panel, which was limited to those
Trusts with data for all 3 years (see Appendix C, Supplemental
Digital Content 4, http://links.lww.com/MLR/B449).
RESULTS
Index Discharges
Between April 2010 and February 2013, 158 Trusts
conducted hip replacement surgery and 158 Trusts conducted
knee replacement surgery. Of these, 26 of the hip replace-
ment Trusts and 33 of the knee replacement Trusts did not
report PROMs data for at least 2 of the 3 years, leaving us
with 132 and 125 Trusts for the 2 surgeries, respectively.
We excluded only a small number of patients due to
missing data for case-mix adjustment (6589 and 7256 for hip
and knee replacement patients, respectively). Our analysis
included 135,066 patients discharged alive following hip
replacement (corresponding to 347.2 procedures per Trust
per year, with a range from 70 to 1174), and 138,042 patients
discharged following knee replacement (371.0 procedures
per Trust per year, range 62–1148). The characteristics of
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both groups of patients changed only slightly between 2010
and 2013 (Table 1). For example, for both procedures the
average length of hospital stay decreased across the study
period, from 6.05 days in 2010 to 5.39 days in 2013 for hip
replacements, and from 6.05 days in 2010 to 5.38 days in
2013 for knee replacements.
Across the 3 years, 71,168 hip replacement patients
returned both preoperative and postoperative PROMs ques-
tionnaires and 70,329 did so for knee replacement, equating
to response rates of 52.7% and 50.9%, respectively. There
was substantial variation in response rates among Trusts,
ranging from 12.1% to 84.9% for hip replacement and from
8.6% to 100% for knee replacement. Mean response rates
improved slightly across the 3 financial years (50.1%, 51.7%,
and 53.5% for hip replacement, and 47.8%, 52.5%, and
57.1% for knee replacement, in 2010/2011, 2011/2012, and
2012/2013, respectively). Among the patients receiving hip
replacements between April 2010 and February 2013, 0.99%
died in hospital within 6 months of discharge, and for knee
replacement the equivalent figure was 0.88%.
Trends in Readmissions and Health Gain
For hip replacement, risk-adjusted readmission rates
decreased by 1.6% from 6.5% in 2010 to 4.9% in 2013.
Similarly, for knee replacement risk-adjusted readmission
rates fell by 1.5% from 6.3% in 2010 to 4.8% in 2013
(Fig. 1). In total, 84.1% of Trusts showed a reduction in risk-
adjusted readmission rate following hip replacement during
this period, whereas 75.8% did so for knee replacement
(Appendix D, Supplemental Digital Content 5, http://links.
lww.com/MLR/B450).
For both procedures, patients tended to report higher
quality-of-life 6 months after the surgery than before, and
these health gains tended to increase over time (Table 1
and Fig. 2). For example, the risk-adjusted gain in EQ-5D
following hip replacement increased by 0.03 from 0.39 in
April 2010 to 0.42 in March 2013. Likewise, gain in EQ-5D
following knee replacement increased by 0.02 over the same
time period, from 0.29 to 0.31. Improvements in these
measures were reported by 83.8% and 81.4% of Trusts,
respectively.
Panel Data Models
Reductions in risk-adjusted readmission rates were
associated with improvements in health gain for both groups
of patients and all metrics. For example, an absolute 1 per-
centage point decline in the risk-adjusted readmission rate
following hip replacement was associated with a 0.004 (95%
confidence interval, 0.002–0.006) unit increase in health gain
measured by EQ-5D for those patients (Table 2).
When we controlled for response rates (Appendix E,
Supplemental Digital Content 6, http://links.lww.com/MLR/
B451), our results showed no substantial difference in com-
parison with the findings from the main model. Restricting the
sample to Trusts with a minimum response rate of 60% (N = 53
for hip replacement, and N = 61 for knee replacement) showed
small reductions in coefficient sizes for EQ-VAS and Oxford
Hip Score in comparison with the main model (Appendix G,
Supplemental Digital Content 8, http://links.lww.com/MLR/
B453). Changes in health gain remained statistically significant
for all PROMs. When restricting our study sample to Trusts
with complete data, we found an increase in coefficient size for
TABLE 1. Summary Statistics for NHS Trusts
Hip Replacement Knee Replacement
FY 2010/
2011
FY 2011/
2012
FY 2012/
2013
FY 2010/
2011
FY 2011/
2012
FY 2012/
2013
Variables Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
No. operations 350.65 184.09 361.66 192.12 329.67 178.86 384.18 207.38 381.51 200.15 347.56 186.29
Patient age (y) 68.15 1.97 68.10 1.97 68.12 2.01 67.08 2.06 67.20 2.17 67.20 2.24
Female (%) 60.66 4.06 60.65 3.35 60.37 3.77 57.67 4.36 58.24 3.63 57.84 3.93
White (%) 96.27 6.31 96.17 6.80 95.71 7.65 95.53 7.08 95.18 7.48 95.35 7.63
Black (%) 0.90 2.52 0.87 2.32 1.08 3.07 1.20 3.46 1.29 3.76 1.14 3.11
Asian (%) 0.68 1.18 0.58 0.83 0.63 0.98 1.20 1.97 1.10 1.64 1.02 1.50
Living in rural areas (%) 13.40 11.37 13.68 11.66 13.33 11.14 12.61 10.75 12.99 11.23 12.86 10.62
Length of hospital stay (d) 6.05 0.95 5.58 1.14 5.39 1.00 6.05 1.15 5.60 1.22 5.38 1.09
No. admissions from least socioeconomically
deprived areas
292.75 156.41 316.29 164.88 270.33 145.55 335.90 205.80 335.20 191.47 298.41 169.54
No. admissions from medium socioeconomically
deprived areas
372.41 192.67 389.13 180.59 361.04 180.63 412.95 217.93 409.62 200.65 381.17 194.37
No. admissions from highest socioeconomically
deprived areas
389.27 191.42 375.53 222.47 359.64 196.46 405.58 194.19 394.70 204.72 366.66 188.88
Charlson comorbidity index 0.28 0.07 0.29 0.08 0.33 0.07 0.27 0.06 0.27 0.06 0.33 0.06
Adjusted 30-day readmission rate (%) 6.51 2.37 5.97 2.07 4.92 1.74 6.26 2.24 6.16 2.00 4.87 1.62
Change in risk-adjusted EQ-5D (D) 0.39 0.03 0.41 0.03 0.42 0.03 0.29 0.03 0.30 0.03 0.31 0.03
Change in risk-adjusted EQ-VAS (D) 8.66 1.99 9.66 1.64 11.02 1.83 2.87 1.73 4.09 1.62 4.90 1.44
Change in risk-adjusted Oxford Knee Score (D) 19.34 1.28 19.78 1.30 20.61 1.23 — — — — — —
Change in risk-adjusted Oxford Hip Score (D) — — — — — — 14.57 1.30 14.86 1.18 15.59 1.19
No. NHS Trusts 127 — 130 — 132 — 123 — 125 — 124
Summary statistics are calculated across Trusts by financial year and procedure separately.
EQ-5D indicates EuroQuol five dimensions questionaire; EQ-VAS, EuroQuol visual analogue scales; FY, Financial year; NHS, National Health Service.
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EQ-VAS in hip and knee replacements, but no change in co-
efficients sizes for all other PROMs measures (Appendix C,
Supplemental Digital Content 4, http://links.lww.com/MLR/
B449). We found no significant associations between health
gain and mortality rates.
DISCUSSION
We studied a period that was marked by a sustained focus
on readmission reduction in England (2010–2013), over which
time risk-adjusted hospital readmission rates fell from 6.5% to
4.9% for patients admitted for hip replacement, and from 6.2%
to 4.8% for knee replacement. We found that those hospital
Trusts that experienced greater reductions in risk-adjusted re-
admission rates during this period also tended to show greater
improvements in risk-adjusted health gain. For hip replacement,
each percentage point reduction in risk-adjusted readmission
rates was associated with an additional improvement in general
health gain of 0.004 according to EQ-5D and an additional
improvement of 0.21 in procedure-specific quality-of-life, over
and above what would otherwise be expected. Corresponding
improvements for knee replacement were 0.003 and 0.14. These
associations were modest, and lower than those that are usually
considered to be clinically significant (ie, 0.14 for EQ-5D, 8.4
for Oxford Hip Score, and 3.8 for Oxford Knee Score),35 though
their significance for patients will depend on how the in-
cremental health gains are distributed across the populations
concerned. Importantly, we did not find evidence that reductions
in readmissions were associated with deteriorations in patient-
reported outcomes. Rather, readmission reductions were asso-
ciated with modest benefits.
To our knowledge, this is the first study to explore the
relationship between readmissions and patient-reported out-
comes at the hospital level and over time. Previous research
has explored the links between readmissions and other
measures of care quality, for example, the existence of a
climate of patient safety during the initial hospital stay,6 and
the approach to discharge coordination during a patients’
transitional care period.8 One study examined whether
patient-reported outcomes following hip and knee replace-
ment correlated with readmission rates, but in that study
readmission rates were calculated over 6 months and relied
upon self-reported data.39
Strengths and Limitations
We compared readmission rates with health gain at
6 months, to examine whether readmission reductions are asso-
ciated with longer-term “spillover” effects for patient health.
Six months was selected by the PROMs program in England as
the earliest time for assessment of benefit postsurgery,39 following
a pilot study that concluded that clinical benefits would be
observable to the patient by this point.40 However, outcomes may
continue to improve,41 and other joint registries use longer time
horizons for assessing patient outcomes.42 One concern for our
study was that, although the readmission metric reflected every
FIGURE 1. Trends in risk-adjusted, 30-day readmission rates
across all Trusts. FY indicates Financial year.
FIGURE 2. Trends in patient-reported outcome measures
(average EQ-5D; EQ-VAS; Oxford Hip and Knee Score across
all Trusts). EQ-5D indicates EuroQuol five dimensions ques-
tionaire; EQ-VAS, EuroQuol visual analogue scales; FY, Finan-
cial year.
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patient who was discharged alive, our measurement of health gain
was necessarily restricted to those who returned the PROMs
questionnaires. Previous studies have indicated that respondents to
PROMs questionnaires have fewer preoperative conditions than
nonrespondents,43 have higher rates of literacy,44 and lower rates
of cognitive impairment, including dementia.45 To investigate
this potential threat to the validity of our study, we conducted
sensitivity analysis that in addition controlled for the Trust-level
response rate for each year. This did not materially change our
findings (Appendix E, Supplemental Digital Content 6, http://
links.lww.com/MLR/B451), nor did controlling for the 6-month
mortality rate (Appendix F, Supplemental Digital Content 7,
http://links.lww.com/MLR/B452). We also explored the impacts
of restricting the study sample to Trusts with a minimum response
rate of 60%, and found only a small change in coefficient sizes
compared with the main model (Appendix G, Supplemental
Digital Content 8, http://links.lww.com/MLR/B453).
Other studies have examined specific interventions aiming
to reduce readmission rates (such as telephone helplines) but we
aimed to assess a wide set of initiatives reflective of routine
practice. Our nonexperimental design allowed us to compare
trends over time in risk-adjusted readmission rates with trends
over time in health gain among a large and representative sample
of hospitals. The study benefited from a large database that was
established in 2009 and now contains patient-reported outcomes
for over 270,000 patients before and after hip or knee replacement
surgery. We risk-adjusted both the readmission rates and PROMs
to account for systematic differences between Trusts in observed
patient characteristics, and also adopted a panel data modeling
method to minimize confounding caused by constant differences
in Trust characteristics (observed or unobserved). However, like
any observational study, it is unlikely to discount entirely the
possibility that other factors explained the associations seen. Our
findings are susceptible to changes in case-mix over time and
between Trusts, which cannot fully be reflected within risk-
adjustment models applied to existing data, and to time-varying
confounders, such as the establishment of specialist hip and knee
centers, for example, the opening of the Orthopaedic Unit at The
Mid Yorkshire Hospitals NHS Trust in 2013.46
Further studies could examine the mechanism of effect, for
example, whether our findings reflect the impact of interventions
aimed at reducing readmission rates on health gain (such as
improved discharge support for patients), or efforts to improve
both metrics simultaneously (such as perioperative rehabilitation
programs).47 These studies might benefit from collecting PROMs
data on a more frequent basis, to test for deviations in patient
health at around the time of the readmission. Studies could also
explore whether our findings will generalize to other patient
groups (eg, medical as well as surgical admissions), settings, and
health care systems.
CONCLUSIONS
Declines in readmission rates after hip and knee replace-
ment in England were accompanied by modest improvements in
patient-reported health gain. These results persisted across differ-
ent measures of patient-reported health status, thereby suggesting
that readmission reductions have not resulted in unintended harm
to patients, as previously feared. It is possible that readmission
rates and patient-reported outcome measures relate to different
dimensions of quality, and that although improvements in each are
reflective of gains for patients, these gains materialize through
different mechanisms.
Our findings underscore the need for more systematic
approaches to collect patient-reported outcomes data across
health care systems,48 so that health gains can be studied more
directly than is currently possible. Indeed, this study is an ex-
ample of how large databases of patient-reported outcomes can
be analyzed to produce insights about health care quality.
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